Selected research
Market Structure
Global Fluoxetine Hydrochloride (Prozac) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Fluoxetine Hydrochloride (Prozac) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Fluoxetine Hydrochloride (Prozac) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Fluoxetine Hydrochloride (Prozac) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fluoxetine Hydrochloride (Prozac) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Fluoxetine Hydrochloride (Prozac) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Fluoxetine Hydrochloride (Prozac) include Alembic Pharmaceuticals, Alvogen, Aurobindo Pharma, Changzhou Siyao Pharmaceutical, Dr.Reddy's Laboratories, Lannett Company, Pharmaceutical Associates Inc., Suzhou YUSHI Pharmaceutical and Torrent Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Fluoxetine Hydrochloride (Prozac) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Fluoxetine Hydrochloride (Prozac) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Fluoxetine Hydrochloride (Prozac) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fluoxetine Hydrochloride (Prozac) market size, projected growth trends, production technologies, key applications, and end-use industries.
Fluoxetine Hydrochloride (Prozac) Segment by Company
Alembic Pharmaceuticals
Alvogen
Aurobindo Pharma
Changzhou Siyao Pharmaceutical
Dr.Reddy's Laboratories
Lannett Company
Pharmaceutical Associates Inc.
Suzhou YUSHI Pharmaceutical
Torrent Pharmaceuticals
Wockhardt
Mylan
Sandoz
Sun Pharmaceutical
Teva
Fluoxetine Hydrochloride (Prozac) Segment by Type
Tablets
Capsules
Fluoxetine Hydrochloride (Prozac) Segment by Application
Panic Disorder
Obsessive-Compulsive Disorder
Bulimia Nervosa
Depression
Others
Fluoxetine Hydrochloride (Prozac) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fluoxetine Hydrochloride (Prozac) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fluoxetine Hydrochloride (Prozac) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fluoxetine Hydrochloride (Prozac).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Fluoxetine Hydrochloride (Prozac) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fluoxetine Hydrochloride (Prozac) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fluoxetine Hydrochloride (Prozac) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Fluoxetine Hydrochloride (Prozac) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Capsules
Applications
- Panic Disorder
- Obsessive-Compulsive Disorder
- Bulimia Nervosa
- Depression
- Others
Companies covered
- Alembic Pharmaceuticals
- Alvogen
- Aurobindo Pharma
- Changzhou Siyao Pharmaceutical
- Dr.Reddy's Laboratories
- Lannett Company
- Pharmaceutical Associates Inc.
- Suzhou YUSHI Pharmaceutical
- Torrent Pharmaceuticals
- Wockhardt
- Mylan
- Sandoz
- Sun Pharmaceutical
- Teva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Fluoxetine Hydrochloride (Prozac) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Fluoxetine Hydrochloride (Prozac) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Fluoxetine Hydrochloride (Prozac) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Fluoxetine Hydrochloride (Prozac) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Fluoxetine Hydrochloride (Prozac) Market Dynamics
- 2.1 Fluoxetine Hydrochloride (Prozac) Industry Trends
- 2.2 Fluoxetine Hydrochloride (Prozac) Industry Drivers
- 2.3 Fluoxetine Hydrochloride (Prozac) Industry Opportunities and Challenges
- 2.4 Fluoxetine Hydrochloride (Prozac) Industry Restraints
3 Fluoxetine Hydrochloride (Prozac) Market by Manufacturers
- 3.1 Global Fluoxetine Hydrochloride (Prozac) Revenue by Manufacturers (2021-2026)
- 3.2 Global Fluoxetine Hydrochloride (Prozac) Sales by Manufacturers (2021-2026)
- 3.3 Global Fluoxetine Hydrochloride (Prozac) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Fluoxetine Hydrochloride (Prozac) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Fluoxetine Hydrochloride (Prozac) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Fluoxetine Hydrochloride (Prozac) Manufacturers, Product Type & Application
- 3.7 Global Fluoxetine Hydrochloride (Prozac) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Fluoxetine Hydrochloride (Prozac) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Fluoxetine Hydrochloride (Prozac) Players Market Share by Revenue in 2025
- 3.8.3 2025 Fluoxetine Hydrochloride (Prozac) Tier 1, Tier 2, and Tier 3
4 Fluoxetine Hydrochloride (Prozac) Market by Type
- 4.1 Fluoxetine Hydrochloride (Prozac) Type Introduction
- 4.1.1 Tablets
- 4.1.2 Capsules
- 4.2 Global Fluoxetine Hydrochloride (Prozac) Sales by Type
- 4.2.1 Global Fluoxetine Hydrochloride (Prozac) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Fluoxetine Hydrochloride (Prozac) Sales by Type (2021-2032)
- 4.2.3 Global Fluoxetine Hydrochloride (Prozac) Sales Market Share by Type (2021-2032)
- 4.3 Global Fluoxetine Hydrochloride (Prozac) Revenue by Type
- 4.3.1 Global Fluoxetine Hydrochloride (Prozac) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Fluoxetine Hydrochloride (Prozac) Revenue by Type (2021-2032)
- 4.3.3 Global Fluoxetine Hydrochloride (Prozac) Revenue Market Share by Type (2021-2032)
5 Fluoxetine Hydrochloride (Prozac) Market by Application
- 5.1 Fluoxetine Hydrochloride (Prozac) Application Introduction
- 5.1.1 Panic Disorder
- 5.1.2 Obsessive-Compulsive Disorder
- 5.1.3 Bulimia Nervosa
- 5.1.4 Depression
- 5.1.5 Others
- 5.2 Global Fluoxetine Hydrochloride (Prozac) Sales by Application
- 5.2.1 Global Fluoxetine Hydrochloride (Prozac) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Fluoxetine Hydrochloride (Prozac) Sales by Application (2021-2032)
- 5.2.3 Global Fluoxetine Hydrochloride (Prozac) Sales Market Share by Application (2021-2032)
- 5.3 Global Fluoxetine Hydrochloride (Prozac) Revenue by Application
- 5.3.1 Global Fluoxetine Hydrochloride (Prozac) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Fluoxetine Hydrochloride (Prozac) Revenue by Application (2021-2032)
- 5.3.3 Global Fluoxetine Hydrochloride (Prozac) Revenue Market Share by Application (2021-2032)
6 Global Fluoxetine Hydrochloride (Prozac) Sales by Region
- 6.1 Global Fluoxetine Hydrochloride (Prozac) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Fluoxetine Hydrochloride (Prozac) Sales by Region (2021-2032)
- 6.2.1 Global Fluoxetine Hydrochloride (Prozac) Sales by Region (2021-2026)
- 6.2.2 Global Fluoxetine Hydrochloride (Prozac) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Fluoxetine Hydrochloride (Prozac) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Fluoxetine Hydrochloride (Prozac) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Fluoxetine Hydrochloride (Prozac) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Fluoxetine Hydrochloride (Prozac) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Fluoxetine Hydrochloride (Prozac) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Fluoxetine Hydrochloride (Prozac) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Fluoxetine Hydrochloride (Prozac) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Fluoxetine Hydrochloride (Prozac) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Fluoxetine Hydrochloride (Prozac) Revenue by Region
- 7.1 Global Fluoxetine Hydrochloride (Prozac) Revenue by Region
- 7.1.1 Global Fluoxetine Hydrochloride (Prozac) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Fluoxetine Hydrochloride (Prozac) Revenue by Region (2021-2026)
- 7.1.3 Global Fluoxetine Hydrochloride (Prozac) Revenue by Region (2027-2032)
- 7.1.4 Global Fluoxetine Hydrochloride (Prozac) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Fluoxetine Hydrochloride (Prozac) Revenue (2021-2032)
- 7.2.2 North America Fluoxetine Hydrochloride (Prozac) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Fluoxetine Hydrochloride (Prozac) Revenue (2021-2032)
- 7.3.2 Europe Fluoxetine Hydrochloride (Prozac) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Fluoxetine Hydrochloride (Prozac) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Fluoxetine Hydrochloride (Prozac) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Fluoxetine Hydrochloride (Prozac) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Fluoxetine Hydrochloride (Prozac) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Alembic Pharmaceuticals
- 8.1.1 Alembic Pharmaceuticals Company Information
- 8.1.2 Alembic Pharmaceuticals Business Overview
- 8.1.3 Alembic Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Alembic Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.1.5 Alembic Pharmaceuticals Recent Developments
- 8.2 Alvogen
- 8.2.1 Alvogen Company Information
- 8.2.2 Alvogen Business Overview
- 8.2.3 Alvogen Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Alvogen Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.2.5 Alvogen Recent Developments
- 8.3 Aurobindo Pharma
- 8.3.1 Aurobindo Pharma Company Information
- 8.3.2 Aurobindo Pharma Business Overview
- 8.3.3 Aurobindo Pharma Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Aurobindo Pharma Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.3.5 Aurobindo Pharma Recent Developments
- 8.4 Changzhou Siyao Pharmaceutical
- 8.4.1 Changzhou Siyao Pharmaceutical Company Information
- 8.4.2 Changzhou Siyao Pharmaceutical Business Overview
- 8.4.3 Changzhou Siyao Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Changzhou Siyao Pharmaceutical Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.4.5 Changzhou Siyao Pharmaceutical Recent Developments
- 8.5 Dr.Reddy's Laboratories
- 8.5.1 Dr.Reddy's Laboratories Company Information
- 8.5.2 Dr.Reddy's Laboratories Business Overview
- 8.5.3 Dr.Reddy's Laboratories Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Dr.Reddy's Laboratories Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.5.5 Dr.Reddy's Laboratories Recent Developments
- 8.6 Lannett Company
- 8.6.1 Lannett Company Company Information
- 8.6.2 Lannett Company Business Overview
- 8.6.3 Lannett Company Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Lannett Company Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.6.5 Lannett Company Recent Developments
- 8.7 Pharmaceutical Associates Inc.
- 8.7.1 Pharmaceutical Associates Inc. Company Information
- 8.7.2 Pharmaceutical Associates Inc. Business Overview
- 8.7.3 Pharmaceutical Associates Inc. Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Pharmaceutical Associates Inc. Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.7.5 Pharmaceutical Associates Inc. Recent Developments
- 8.8 Suzhou YUSHI Pharmaceutical
- 8.8.1 Suzhou YUSHI Pharmaceutical Company Information
- 8.8.2 Suzhou YUSHI Pharmaceutical Business Overview
- 8.8.3 Suzhou YUSHI Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Suzhou YUSHI Pharmaceutical Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.8.5 Suzhou YUSHI Pharmaceutical Recent Developments
- 8.9 Torrent Pharmaceuticals
- 8.9.1 Torrent Pharmaceuticals Company Information
- 8.9.2 Torrent Pharmaceuticals Business Overview
- 8.9.3 Torrent Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Torrent Pharmaceuticals Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.9.5 Torrent Pharmaceuticals Recent Developments
- 8.10 Wockhardt
- 8.10.1 Wockhardt Company Information
- 8.10.2 Wockhardt Business Overview
- 8.10.3 Wockhardt Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Wockhardt Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.10.5 Wockhardt Recent Developments
- 8.11 Mylan
- 8.11.1 Mylan Company Information
- 8.11.2 Mylan Business Overview
- 8.11.3 Mylan Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Mylan Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.11.5 Mylan Recent Developments
- 8.12 Sandoz
- 8.12.1 Sandoz Company Information
- 8.12.2 Sandoz Business Overview
- 8.12.3 Sandoz Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Sandoz Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.12.5 Sandoz Recent Developments
- 8.13 Sun Pharmaceutical
- 8.13.1 Sun Pharmaceutical Company Information
- 8.13.2 Sun Pharmaceutical Business Overview
- 8.13.3 Sun Pharmaceutical Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Sun Pharmaceutical Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.13.5 Sun Pharmaceutical Recent Developments
- 8.14 Teva
- 8.14.1 Teva Company Information
- 8.14.2 Teva Business Overview
- 8.14.3 Teva Fluoxetine Hydrochloride (Prozac) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Teva Fluoxetine Hydrochloride (Prozac) Product Portfolio
- 8.14.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Fluoxetine Hydrochloride (Prozac) Value Chain Analysis
- 9.1.1 Fluoxetine Hydrochloride (Prozac) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Fluoxetine Hydrochloride (Prozac) Production Mode & Process
- 9.2 Fluoxetine Hydrochloride (Prozac) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Fluoxetine Hydrochloride (Prozac) Distributors
- 9.2.3 Fluoxetine Hydrochloride (Prozac) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst